Pierre Sommadossi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pierre sommadossi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pierre Sommadossi Today - Breaking & Trending Today

Marquette Asset Management LLC Buys 22,301 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)

Marquette Asset Management LLC raised its stake in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 89.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 47,166 shares of the company’s stock after purchasing an additional 22,301 shares during the period. Marquette […] ....

Dwayne Foster , Jean Pierre Sommadossi , Atea Pharmaceuticals Inc , Securities Exchange Commission , Atea Pharmaceuticals , Acuitas Investments , China Universal Asset Management Co , Sg Americas Securities , News Ratings For Atea Pharmaceuticals Daily , Marquette Asset Management , Capital Management , Quarter For Atea Pharmaceuticals , Atea Pharmaceuticals Trading , Free Report , Asset Management , Universal Asset Management , Gladius Capital Management , Get Free Report , Pierre Sommadossi , Exchange Commission , Visit Holdingschannel , Atea Pharmaceuticals Daily , Nasdaq Avir , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2023 Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2023 Earnings Call Transcript February 28, 2024 Atea Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Fourth Quarter 2023 Financial Results and Business Update […] ....

Jean Pierre Sommadossi , John Vavricka , Janet Hammond , Andrea Corcoran , World Health Organization , World Health , Fast Track , Pierre Sommadossi , Highest Tax ,

Jean-Pierre Sommadossi Sells 56,910 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Stock

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Free Report) CEO Jean-Pierre Sommadossi sold 56,910 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $3.85, for a total value of $219,103.50. Following the sale, the chief executive officer now owns 116,557 shares of the company’s […] ....

Jean Pierre Sommadossi , Atea Pharmaceuticals , Hedge Funds Weigh In On Atea Pharmaceuticals , News Ratings For Atea Pharmaceuticals Daily , Sg Americas Securities , Stonepine Capital Management , Atea Pharmaceuticals Inc , Atea Pharmaceuticals Stock Performance , Capital Management , Get Free Report , Pierre Sommadossi , Funds Management , Atea Pharmaceuticals Daily , Nasdaq Avir , Insider Trading , Nsider Trades ,

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Third Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions]. ....

United States , Jon Miller , Andrea Corcoran , Maxwell Skor , Janet Hammond , John Vavricka , Arantxa Horga , Deric Joseph , Jonae Barnes , Jean Pierre Sommadossi , Jonathan Miller , Roanna Ruiz , Atea Pharmaceuticals , Morgan Stanley , Corporate Communications At Atea Pharmaceuticals , Atea Pharmaceuticals Inc , Atea Pharmaceuticals Third Quarter , Exchange Commission , Call Transcript November , Business Update Conference , Senior Vice President , Investor Relations , Corporate Communications , Chief Executive Officer , Chief Development Officer , Chief Medical Officer ,

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2023 Earnings Call Transcript November 8, 2023 Atea Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.46. Operator: Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals Third Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions]. I would now like to turn the […] ....

United States , Jean Pierre Sommadossi , Andrea Corcoran , Arantxa Horga , Deric Joseph , John Vavricka , American Association , Liver Diseases , Pierre Sommadossi , Real Estate , American Stocks To Buy Heading ,